Recent Updates
Recently added Catalysts
VOR Positive Sentiment Score: 70/100

Vor Bio to Participate in the Oppenheimer's 35th Annual Healthcare Life Sciences Conference

Monday, February 3, 2025 1 min read
Key Takeaway: Vor Bio (Nasdaq: VOR) has announced its participation in the Oppenheimer's 35th Annual Healthcare Life Sciences Conference. The event will feature a fireside chat and virtual 1x1 investor meetings scheduled for February 12. Vor Bio specializes in cell and genome engineering, aiming to transform therapies for patients with blood cancers by developing targeted treatments using engineered stem cells. A live webcast of the fireside chat will be accessible on their website.

Market Sentiment Analysis

POSITIVE FACTORS

  • Vor Bio is participating in a prominent industry conference.
  • The company's focus is on innovative treatments for blood cancers.
  • The presence at the conference may enhance investor interest.

Full Press Release Details

CAMBRIDGE, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and host virtual 1x1 investor meetings at the Oppenheimer’s 35th Annual Healthcare Life Sciences Conference.
Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
Fireside Chat: Wednesday, February 12th at 12:00pm ET
A live webcast and archived replay of the fireside chat will be available on the investors section of www.vorbio.com.
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Tags

Frequently Asked Questions

When is Vor Bio's fireside chat at the Oppenheimer conference?

The fireside chat is on Wednesday, February 12th at 12:00pm ET.

Where can I watch the fireside chat replay?

The replay will be available on the investors section of www.vorbio.com.

What is Vor Bio's focus in the biopharma industry?

Vor Bio focuses on engineering hematopoietic stem cells for blood cancer therapies.

What type of meetings will Vor Bio host at the conference?

Vor Bio will host virtual 1x1 investor meetings at the conference.

What is the mission of Vor Bio?

Vor Bio aims to change the standard of care for blood cancer patients.

Tags: VOR Viatris Investor Conferences Healthcare Vor Bio healthcare conference Oppenheimer blood cancers clinical-stage
Last updated: Feb 3, 2025